Triple negative breast cancer (TNBC), characterized as being negative for estrogen receptor (ER), progesterone receptor (PR), and human epidermal receptor growth factor 2 (HER2), is the second most common breast cancer subtype and has the worst prognosis. This evidence concerns the gene ESR1 and breast cancer.